Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | FABP6 | P51161 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimedazol SCHEMBL29097803 | 0.90 | MAPT (0.47) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| Dimedazol SCHEMBL28394195 | 0.88 | KDM4E (0.46) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL31268592 | 0.85 | MAPT (0.50) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| Dimedazol SCHEMBL61387 | 0.84 | MAPT (0.45) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| Dimedazol SCHEMBL28639998 | 0.84 | MAPT (0.45) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL3891260 | 0.83 | MAPT (0.56) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL1839055 | 0.83 | MAPT (0.70) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL13373332 | 0.83 | MAPT (0.48) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL12113061 | 0.83 | MAPT (0.61) | MAPTKDM4ETDP1ALDH1A1APEX1 | |
| SCHEMBL3925343 | 0.83 | MAPT (0.48) | MAPTKDM4ETDP1ALDH1A1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1877 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122060375-A | Corrosion-resistant fireproof explosion-proof material, preparation method thereof and application thereof in electric power tunnel | 南昌泰事达电气科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122063164-A | Application of composite hollow nanotube array with core-sheath structure and coated with MOF hydrophobic layer in gas-sensitive moisture resistance | 中国科学院福建物质结构研究所 | 2026-05-19 | — | — | CN | claimed |
| US-12550694-B2 | Selective deposition for integrated circuit interconnect structures | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2026-02-10 | — | — | US | claimed |
| US-12496548-B2 | Hydrophobic MOF-based porous liquid carbon capture absorbent and preparation method therefor | HUANENG CLEAN ENERGY RESEARCH INSTITUTE (CN) | 2025-12-16 | — | — | US | claimed |
| CN-119994394-A | Diaphragm, preparation method thereof and lithium ion battery | 蜂巢能源科技股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-116093348-B | Preparation method of cobalt-nitrogen-carbon material with high electrocatalytic performance | 中钢集团南京新材料研究院有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119505275-B | MOF-CGC material and preparation method and application thereof | 宁波大学 | 2025-04-29 | — | — | CN | claimed |
| US-12278143-B2 | Method of providing a workpiece including low resistance interconnect low-resistance interconnect | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2025-04-15 | — | — | US | claimed |
| CN-119793232-A | MOF crystal-glass composite membrane for gas separation and preparation method and application thereof | 衢州膜材料创新研究院 | 2025-04-11 | — | — | CN | claimed |
| US-5405839-A | Vitamin B12 antagonist; inhibits cell growth; anticancer agents | TEIJIN LIMITED (JP) | 1995-04-11 | — | — | US | claimed |
| EP-0251760-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 1994-01-26 | — | — | EP | claimed |
| US-5140055-A | Improved high speed grip performance | BRIDGESTONE CORPORATION (JP) | 1992-08-18 | — | — | US | claimed |
| US-4752584-A | Process for the production of inoculum for anaerobic fermentation of coenzyme B12 | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1988-06-21 | — | — | US | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |
| US-4659661-A | Process for the preparation of fermentation broth for coenzyme B12 and other corrinoid production | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1987-04-21 | — | — | US | claimed |
| EP-0030684-B1 | TEST COMPOSITION FOR PEROXIDATIVELY ACTIVE SUBSTANCES, TEST DEVICE CONTAINING THE COMPOSITION, PROCESS FOR PREPARING SAME AND METHOD FOR THE DETERMINATION OF PEROXIDATIVELY ACTIVE SUBSTANCES | MILES LABORATORIES, INC. (US) | 1983-03-16 | — | — | EP | claimed |
| US-4329459-A | ENDOPEROXIDE CYCLOXGENASE INHIBITORS | THE UPJOHN COMPANY (US) | 1982-05-11 | — | — | US | claimed |
| US-4278439-A | BENZIMIDAZOLES | MILES LABORATORIES, INC. (US) | 1981-07-14 | — | — | US | claimed |
| EP-0030684-A1 | Test composition for peroxidatively active substances, test device containing the composition, process for preparing same and method for the determination of peroxidatively active substances | MILES LABORATORIES, INC. (US) | 1981-06-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12550694-B2 | Selective deposition for integrated circuit interconnect structures | CAPRIN1, PIEZO1, GJB2 | MAPT 2143/4885KDM4E 279/4885TDP1 1727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.